Recombinant galectin-1 and its genetic delivery suppress collagen- induced arthritis via T cell apoptosis

Journal of Experimental Medicine

Volumn 190, Issue 3, 1999, Pages 385-397

  Rabinovich, Gabriel A ^a   Daly, Gordon ^b   Dreja, Hanna ^b   Tailor, Hitakshi ^b   Riera, Clelia M ^a   Hirabayashi, Jun ^c   Chernajovsky, Yuti ^b,d  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c TEIKYO UNIVERSITY   (Japan)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Collagen induced arthritis; Galectin 1; Gene therapy; T cells

Indexed keywords

COLLAGEN TYPE 2; CYTOKINE; GALECTIN; IMMUNOGLOBULIN G; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TARGETING; GENE THERAPY; HELPER CELL; HYBRIDOMA; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; T LYMPHOCYTE; THYMOCYTE;

EID: 0033517113     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.3.385     Document Type: Article

References (56)

1. Barondes, S.H., D.N.W. Cooper, M.A. Gitt, and H. Leffler. 1994. Galectins: structure and function of a large family of animal lectins. J. Biol. Chem. 269:20807-20810.
2. Barondes, S.H., V. Castronovo, D.N.W. Cooper, R.D. Cummings, K. Drickamer, T. Feizi, M.A. Gitt, J. Hirabayashi, R.C. Hughes, K. Kasai, et al. 1994. Galectins: a family of animal β-galactoside-binding lectins. Cell. 76:597-598.
3. Hirabayashi, J., and K. Kasai. 1993. The family of metazoan metal-independent β-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 3:297-304.
4. Leffler, H. 1997. Introduction to galectins. Trends Glycosci. Glycotech. 45:9-19.
5. Poirrier, F., and E.J. Robertson. 1993. Normal development of mice carrying a null mutation in the gene encoding the L-14 S-type lectin. Development. 119:1229-1236.
6. Van den Brüle, F.A., C. Buicu, M. Baldet, M.E. Sobel, D.N.W. Cooper, P. Marschal, and V. Castronovo. 1995. GAL-1 modulates human melanoma cell adhesion to laminin. Biochem. Biophys. Res. Commun. 209:760-767.
7. Wells, V., and L. Mallucci. 1991. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell. 64:91-97.
8. Blaser, C., M. Kaufmann, C. Muller, C. Zimmerman, V. Wells, L. Mallucci, and H. Pircher. 1998. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 28:2311-2319.
9. Allione, A., V. Wells, G. Forni, L. Mallucci, and F. Novelli. 1998. Beta-galactoside-binding protein (β-GBP) alters the cell cycle, up-regulates expression of the α- and β-chains of the IFN-γ receptor, and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes. J. Immunol. 161:2114-2119.
10. Bresalier, R.S., N. Mazurek, L.R. Sternberg, J.C. Bird, C.K. Yunker, P.N. Makker, and A. Raz. 1998. Metastasis of human colon cancer is altered by modifying expression of the β-galactoside binding protein galectin-3. Gastroenterology. 115:287-296.
11. Levy, G., R. Tarrab-Hazdai, and V.I. Teichberg. 1983. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 13: 500-507.
12. Offner, H., B. Celnik, T. Bringman, D. Casentini-Borocz, G.E. Nedwin, and A. Vanderbark. 1990. Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 28:177-184.
13. Perillo, N.L., K.E. Pace, J.J. Seilhamer, and L.G. Baum. 1995. Apoptosis of T-cells mediated by GAL-1. Nature. 378: 736-739.
14. Rabinovich, G.A., M.M. Iglesias, N.M. Modesti, L.F. Castagna, C.W. Todel, C.M. Riera, and C.E. Sotomayor. 1998. Activated rat macrophages produce a GAL-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J. Immunol. 160:4831-4840.
15. Perillo, N.L., C.H. Uittenbogaart, J.T. Nguyen, and L.G. Baum. 1997. GAL-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J. Exp. Med. 185:1851-1858.
16. Baum, L.G., M. Pang, N.L. Perillo, T. Wu, A. Delegaene, C.H. Uittenbogaart, M. Fukuda, and J.J. Seilhamer. 1995. Human thymic epithelial cells express an endogenous lectin, GAL-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181:877-887.
17. Baum, L.G., J.J. Seilhamer, M. Pang, W.B. Levine, D. Beynon, and J.A. Berliner. 1995. Synthesis of an endogenous lectin, GAL-1 by human endothelial cells is up-regulated by endothelial cell activation. Glycoconjugate J. 12:63-68.
18. Rabinovich, G.A., L.F. Castagna, C.A. Landa, C.M. Riera, and C.E. Sotomayor. 1996. Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. J. Leukocyte Biol. 59:363-370.
19. Iglesias, M.M., G.A. Rabinovich, V. Ivanovic, C.E. Sotomayor, and C. Wolfenstein-Todel. 1998. GAL-1 from ovine placenta: amino-acid sequence, physiochemical properties and implications in T-cell death. Eur. J. Biochem. 252:400-407.
20. Allen, H.J., D. Sucato, B. Woynarowska, S. Gottstine, A. Sharma, and R.J. Bernacki. 1990. Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro. J. Cell. Biochem. 43:43-57.
21. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Rheumatoid arthritis. Cell. 85:307-310.
22. Chernajovsky, Y., M. Feldmann, and R.N. Maini. 1995. Gene therapy in rheumatoid arthritis via cytokine regulation: future perspectives. Br. Med. Bull. 51:503-516.
23. Durie, F.H., R.A. Fava, and R.J. Noelle. 1994. Collagen-induced arthritis as a model of rheumatoid arthritis. Clin. Immunol. Immunopathol. 73:11-18.
24. Vaishnaw, A.K., J.D. McNally, and K.B. Elkon. 1997. Apoptosis in the rheumatic diseases. Arthritis Rheum. 40:1917-1927.
25. Revillard, J.P., L. Adorini, M. Goldman, D. Kabelitz, and H. Waldmann. 1998. Apoptosis: potential for disease therapies. Immunol. Today. 19:291-293.
26. Gold, R., H.P. Hartung, and H. Lassman. 1997. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immunedefense mechanism. Trends Neurosci. 20:399-404.
27. Brunsberg, U., K. Gustafsson, L. Jansson, E. Michaëlsson, L. Ährlund-Richter, S. Petterson, R. Mattsson, and R. Holmdahl. 1994. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur. J. Immunol. 24:1698-1702.
28. Triantaphyllopoulos, K.A., J.L. Croxford, D. Baker, and Y. Chernajovsky. 1998. Cloning and expression of murine IFN β and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis. Gene Therapy. 5:253-263.
29. Hirabayashi, J., H. Ayaki, G. Soma, and K. Kasai. 1989. Production and purification of a recombinant human 14 kDa β-galactoside-binding lectin. FEBS Lett. 250:161-165.
30. Williams, R.O., M. Feldmann, and R.N. Maini. 1992. Antitumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 89:9784-9788.
31. Mauri, C., R.O. Williams, M. Walmsley, and M. Feldmann. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26:1511-1518.
32. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C.A. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
33. McFarland, H.L., J.M. Critchfield, M.K. Racke, J.P. Mueller, S.H. Nye, S.A. Boehme, and M.J. Lenardo. 1995. Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells. Adv. Exp. Med. Biol. 383:157-166.
34. Rabinovich, G.A., N.M. Modesti, L.F. Castagna, C.A. Landa, C.M. Riera, and C.E. Sotomayor. 1997. Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin. J. Biochem. 122:365-373.
35. Cyster, J.G., D. Fowell, and A.N. Barclay. 1994. Antigen determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation. Int. Immunol. 6:1875-1881.
36. Singer, G.G., A.C. Carrera, A. Marshak-Rothstein, A.C. Martínez, and A.K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-1pr/1pr model. Curr. Opin. Immunol. 6:913-920.
37. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Yin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:935-946.
38. Jorgensen, C., and S. Gay. 1998. Gene therapy in osteoarticular diseases: where are we? Immunol. Today. 19:387-391.
39. Okamoto, K., H. Asahara, T. Kobayashi, H. Matsuno, T. Hasunuma, T. Kobata, T. Sumida, and K. Nishioka. 1998. Induction of apoptosis in rheumatoid synovium by Fas ligand gene transfer. Gene Therapy. 5:331-338.
40. Zhang, H., Y. Yang, J.L. Horton, E.B. Samoilova, T.A. Judge, L.A. Turka, J.M. Wilson, and Y. Chen. 1997. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1951-1957.
41. Varadhachary, A.S., S.N. Perdow, C. Hu, M. Ramanarayanan, and P. Salgame. 1997. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA. 94:5778-5783.
42. Zhang, X., T. Brunner, L. Carter, R.W. Dutton, P. Rogers, L. Bradley, T. Sato, J.C. Reed, D. Green, and S.L. Swain. 1997. Unequal death in T helper cell (Th) 1 and Th2 effectors: Th1, but not Th2 effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837-1849.
43. Mageed, R.A., G. Adams, D. Woodrow, O.L. Podhajcer, and Y. Chernajovsky. 1998. Prevention of collagen-induced arthritis by gene delivery of soluble p75 TNF receptor. Gene Therapy. 5:1584-1592.
44. Triantaphyllopoulos, K.A., R.O. Williams, H. Tailor, and Y. Chernajovsky. 1999. Amelioration of collagen-induced arthritis and suppression of IFN γ, IL-12 and TNF α production by IFN β gene therapy. Arthritis Rheum. 42:90-99.
45. Yang, R.Y., D.K. Hsu, and F.T. Liu. 1996. Expression of galectin-3 modulates T cell growth and apoptosis. Proc. Natl. Acad. Sci. USA. 93:6737-6742.
46. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
47. Cortegano, I., V. del Pozo, B. Cárdaba, B. de Andrés, S. Gallardo, A. del Amo, I. Arrieta, A. Jurado, P. Palomino, F.-T. Liu, and C. Lahoz. 1998. Galectin-3 down-regulates IL-5 gene expression on different cell types. J. Immunol. 161:385-389.
48. Evans, C.H., and P.D. Robbins. 1996. Pathways to gene therapy in rheumatoid arthritis. Curr. Opin. Rheumatol. 8:230-234.
49. Chernajovsky, Y., A. Annenkov, C. Herman, K. Triantaphyllopoulos, D. Gould, H. Dreja, S.V. Moyes, J.L. Croxford, R.A. Mageed, O.L. Podhajcer, and D. Baker. 1998. Gene therapy for rheumatoid arthritis: theoretical considerations. Drugs Aging. 12:29-41.
50. Otani, K., I. Nita, W. Macaulay, H.I. Georgescu, P.D. Robbins, and C.H. Evans. 1996. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J. Immunol. 156: 3558-3562.
51. Chernajovsky, Y., G. Adams, O.L. Podhajcer, G.M. Mueller, P.D. Robbins, and M. Feldmann. 1995. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Therapy. 2:731-735.
52. Vespa, G.N., L.A. Lewis, K.R. Kozak, M. Moran, J.T. Nguyen, L.G. Baum, and M.C. Miceli. 1999. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J. Immunol. 162:799-806.
53. Zhou, T., L. Song, P. Yang, Z. Wang, D. Lui, and R.S. Jope. 1999. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell mediated autoimmune diseases. Nat. Med. 5:42-48.
54. Bohl, D., N. Naffakh, and J.-M. Heard. 1997. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3:299-305.
55. Burt, R.K., W.H. Burns, and S.D. Miller. 1997. Bone marrow transplantation for multiple sclerosis: returning to Pandora's box. Immunol. Today. 12:559-561.
56. Wicks, I., H. Cooley, and J. Szer. 1997. Autologous hemopoietic stem cell transplantation: A possible cure for rheumatoid arthritis? Arthritis Rheum. 40:1005-1011.